CNO FINANCIAL GROUP INC (CNO)
US12621E1038 - Common Stock
Overall CNO gets a fundamental rating of 4 out of 10. We evaluated CNO against 140 industry peers in the Insurance industry. There are concerns on the financial health of CNO while its profitability can be described as average. CNO has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
CNO had positive earnings in the past year.
CNO had a positive operating cash flow in the past year.
In the past 5 years CNO has always been profitable.
In the past 5 years CNO always reported a positive cash flow from operatings.
1.2 Ratios
CNO has a Return On Assets of 0.73%. This is in the lower half of the industry: CNO underperforms 64.03% of its industry peers.
The Return On Equity of CNO (10.20%) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.73% | ||
| ROE | 10.2% | ||
| ROIC | N/A |
ROA(3y)1.42%
ROA(5y)1.27%
ROE(3y)19.66%
ROE(5y)14.65%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
CNO has a Profit Margin (5.98%) which is in line with its industry peers.
CNO's Profit Margin has declined in the last couple of years.
CNO has a Operating Margin of 14.31%. This is in the better half of the industry: CNO outperforms 62.59% of its industry peers.
CNO's Operating Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.31% | ||
| PM (TTM) | 5.98% | ||
| GM | N/A |
OM growth 3Y7.5%
OM growth 5YN/A
PM growth 3Y-5.86%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
CNO has less shares outstanding than it did 1 year ago.
CNO has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, CNO has a worse debt to assets ratio.
2.2 Solvency
CNO has a debt to FCF ratio of 7.02. This is a slightly negative value and a sign of low solvency as CNO would need 7.02 years to pay back of all of its debts.
CNO has a worse Debt to FCF ratio (7.02) than 68.35% of its industry peers.
A Debt/Equity ratio of 1.60 is on the high side and indicates that CNO has dependencies on debt financing.
CNO has a worse Debt to Equity ratio (1.60) than 92.81% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.6 | ||
| Debt/FCF | 7.02 | ||
| Altman-Z | N/A |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | N/A | ||
| Quick Ratio | N/A |
3. Growth
3.1 Past
CNO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 55.02%, which is quite impressive.
The Earnings Per Share has been growing by 12.32% on average over the past years. This is quite good.
Looking at the last year, CNO shows a quite strong growth in Revenue. The Revenue has grown by 13.75% in the last year.
Measured over the past years, CNO shows a decrease in Revenue. The Revenue has been decreasing by -0.47% on average per year.
EPS 1Y (TTM)55.02%
EPS 3Y7.12%
EPS 5Y12.32%
EPS Q2Q%26.14%
Revenue 1Y (TTM)13.75%
Revenue growth 3Y3.17%
Revenue growth 5Y-0.47%
Sales Q2Q%17.91%
3.2 Future
CNO is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.95% yearly.
CNO is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.78% yearly.
EPS Next Y21.23%
EPS Next 2Y10.47%
EPS Next 3Y10.31%
EPS Next 5Y9.95%
Revenue Next Year3.61%
Revenue Next 2Y3.45%
Revenue Next 3Y3.2%
Revenue Next 5Y3.78%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
CNO is valuated reasonably with a Price/Earnings ratio of 9.57.
CNO's Price/Earnings ratio is a bit cheaper when compared to the industry. CNO is cheaper than 67.63% of the companies in the same industry.
CNO's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.35.
CNO is valuated reasonably with a Price/Forward Earnings ratio of 9.73.
Based on the Price/Forward Earnings ratio, CNO is valued a bit cheaper than 60.43% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.86. CNO is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.57 | ||
| Fwd PE | 9.73 |
4.2 Price Multiples
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CNO indicates a somewhat cheap valuation: CNO is cheaper than 63.31% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.22 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.45
PEG (5Y)0.78
EPS Next 2Y10.47%
EPS Next 3Y10.31%
5. Dividend
5.1 Amount
CNO has a Yearly Dividend Yield of 1.70%.
CNO's Dividend Yield is comparable with the industry average which is at 2.96.
CNO's Dividend Yield is slightly below the S&P500 average, which is at 2.30.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.7% |
5.2 History
On average, the dividend of CNO grows each year by 9.10%, which is quite nice.
CNO has paid a dividend for at least 10 years, which is a reliable track record.
CNO has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)9.1%
Div Incr Years12
Div Non Decr Years12
5.3 Sustainability
24.80% of the earnings are spent on dividend by CNO. This is a low number and sustainable payout ratio.
CNO's earnings are growing around the same pace than its dividend. As long as the earnings growth is kept the dividend growth is sustainable.
DP24.8%
EPS Next 2Y10.47%
EPS Next 3Y10.31%
CNO FINANCIAL GROUP INC
NYSE:CNO (12/30/2024, 10:49:56 AM)
36.94
-0.35 (-0.94%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)
Earnings (Next)
Inst Owners98.81%
Inst Owner Change-3.61%
Ins Owners2.03%
Ins Owner Change-0.35%
Market Cap3.81B
Analysts70
Price Target42.23 (14.32%)
Short Float %1.98%
Short Ratio3.07
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.7% |
Dividend Growth(5Y)9.1%
DP24.8%
Div Incr Years12
Div Non Decr Years12
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)40.22%
Min EPS beat(2)33.4%
Max EPS beat(2)47.04%
EPS beat(4)3
Avg EPS beat(4)24.27%
Min EPS beat(4)-20.49%
Max EPS beat(4)47.04%
EPS beat(8)5
Avg EPS beat(8)9.91%
EPS beat(12)7
Avg EPS beat(12)14.37%
EPS beat(16)11
Avg EPS beat(16)13.31%
Revenue beat(2)2
Avg Revenue beat(2)17.13%
Min Revenue beat(2)14.59%
Max Revenue beat(2)19.67%
Revenue beat(4)4
Avg Revenue beat(4)20.17%
Min Revenue beat(4)14.59%
Max Revenue beat(4)24.07%
Revenue beat(8)8
Avg Revenue beat(8)13.78%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.55%
PT rev (3m)23.21%
EPS NQ rev (1m)0%
EPS NQ rev (3m)4.19%
EPS NY rev (1m)0%
EPS NY rev (3m)8.39%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.68%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.91%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.57 | ||
| Fwd PE | 9.73 | ||
| P/S | 0.83 | ||
| P/FCF | 6.22 | ||
| P/OCF | 6.22 | ||
| P/B | 1.42 | ||
| P/tB | 1.42 | ||
| EV/EBITDA | N/A |
EPS(TTM)3.86
EY10.45%
EPS(NY)3.8
Fwd EY10.27%
FCF(TTM)5.94
FCFY16.09%
OCF(TTM)5.94
OCFY16.09%
SpS44.41
BVpS26.04
TBVpS26.04
PEG (NY)0.45
PEG (5Y)0.78
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.73% | ||
| ROE | 10.2% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | 14.31% | ||
| PM (TTM) | 5.98% | ||
| GM | N/A | ||
| FCFM | 13.38% |
ROA(3y)1.42%
ROA(5y)1.27%
ROE(3y)19.66%
ROE(5y)14.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)2.17%
ROCE(5y)1.84%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y7.5%
OM growth 5YN/A
PM growth 3Y-5.86%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.12
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.6 | ||
| Debt/FCF | 7.02 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | N/A | ||
| Profit Quality | 223.71% | ||
| Current Ratio | N/A | ||
| Quick Ratio | N/A | ||
| Altman-Z | N/A |
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)131.43%
Profit Quality(5y)161.63%
High Growth Momentum
Growth
EPS 1Y (TTM)55.02%
EPS 3Y7.12%
EPS 5Y12.32%
EPS Q2Q%26.14%
EPS Next Y21.23%
EPS Next 2Y10.47%
EPS Next 3Y10.31%
EPS Next 5Y9.95%
Revenue 1Y (TTM)13.75%
Revenue growth 3Y3.17%
Revenue growth 5Y-0.47%
Sales Q2Q%17.91%
Revenue Next Year3.61%
Revenue Next 2Y3.45%
Revenue Next 3Y3.2%
Revenue Next 5Y3.78%
EBIT growth 1Y3.85%
EBIT growth 3Y10.91%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y35.17%
FCF growth 3Y-7.46%
FCF growth 5Y12.9%
OCF growth 1Y35.17%
OCF growth 3Y-7.46%
OCF growth 5Y12.9%